Serum glycoproteins and severity of coronary atherosclerosis

American Heart Journal

Volumn 129, Issue 2, 1995, Pages 234-238

  Mori, Tsukasa ^a,b   Sasaki, Jun ^a,b   Kawaguchi, Hiroshi ^a,b   Handa, Koichi ^a,b   Takada, Yoichi ^a,b   Matsunaga, Akira ^a,b   Kono, Suminori ^a,b   Arakawa, Kikuo ^a,b  

^a FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT COMPONENT C4B; FIBRINOGEN; GLYCOPROTEIN; HAPTOGLOBIN; LIPOPROTEIN A; OROSOMUCOID;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGING; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FASTING; FEMALE; GLYCOPROTEINS; HUMAN; MALE; MIDDLE AGE; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 0028899522     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(95)90003-9     Document Type: Article

References (29)

1. The pathogenesis of atherosclerosis
2. The pathogenesis of atherosclerosis-an update
3. A survey of 246 suggested coronary risk factors
4. Leukocytes as a coronary risk factor in a dyslipidemic male population
5. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
6. Serum sialic acid concentration and cardiovascular mortality
7. Lp(a) as a marker for coronary heart disease risk
8. Proline-rich protein is glycoprotein and an acute phase reactant
9. Atherosclerosis and inflammation
10. Serum glycoproteins in coronary artery disease
11. A more meaningful scoring system for determining the severity of coronary heart disease
12. Immunochemical quantitation of antigens by single radial immunodiffusion
13. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
14. Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels
15. Enzymatic determination of total serum cholesterol
16. The PHGLM procedure
17. Tissue-specific regulation of inflammation
18. Monocyte chemoattractant protein-1 in human atheromatous plaques.
19. Physiologic inhibition of human activated protein C by alpha (I)-antitrypsin
20. 2-Macroglobulin binds and inhibits activated protein C
21. The protein C anticoagulant pathway
22. 2-macroglobulin receptor
23. 2-macroglobulin receptor and low-density lipoprotein receptor related protein suggests that this molecule is a multifunctional receptor
24. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-l-lysine polymers and other polycations
25. Inhibition of rabbit platelet aggregation and clot retraction by rabbit and human C-reactive proteins
26. Effects of C-reactive protein on monocyte functions. III. Inhibition of antigen-induced lymphocyte stimulation and lymphokine production
27. Lp(a) as a marker for coronary heart disease risk
28. Transient changes of serum lipoprotein(a) as an acute phase protein
29. Dose Lp(a) act as an acute phase reactant in healthy young women, who underwent cesarean section?